Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'TICK ANTICOAGULANT PEPTIDE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 92 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Rai, R; Sprengeler, PA; Elrod, KC; Young, WB
      Perspectives on factor Xa inhibition

      CURRENT MEDICINAL CHEMISTRY
    2. Himber, J; Refino, CJ; Burcklen, L; Roux, S; Kirchhofer, D
      Inhibition of arterial thrombosis by a soluble tissue factor mutant and active site-blocked factors IXa and Xa in the guinea pig

      THROMBOSIS AND HAEMOSTASIS
    3. Sakariassen, KS; Hanson, SR; Cadroy, Y
      Methods and models to evaluate shear-dependent and surface reactivity-dependent antithrombotic efficacy

      THROMBOSIS RESEARCH
    4. Chu, V; Brown, K; Colussi, D; Gao, JB; Bostwick, J; Kasiewski, C; Bentley, R; Morgan, S; Guertin, K; Pauls, HW; Gong, Y; Zulli, A; Perrone, MH; Dunwiddie, CT; Leadley, RJ
      Pharmacological characterization of a novel factor Xa inhibitor, FXV673

      THROMBOSIS RESEARCH
    5. Abendschein, DR; Baum, PK; Verhallen, P; Eisenberg, PR; Sullivan, ME; Light, DR
      A novel synthetic inhibitor of factor Xa decreases early reocclusion and improves 24-h patency after coronary fibrinolysis in dogs

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    6. Pinto, DJP; Orwat, MJ; Wang, SG; Fevig, JM; Quan, ML; Amparo, E; Cacciola, J; Rossi, KA; Alexander, RS; Smallwood, AM; Luettgen, JM; Liang, L; Aungst, BJ; Wright, MR; Knabb, RM; Wong, PC; Wexler, RR; Lam, PYS
      Discovery of 1-[3-(aminomethyl)phenyl]-N-[3-fluoro-2 '- (methylsulfonyl)-[1,1 '-biphenyl]-4-yl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide (DPC423), a highly potent, selective, and orally bioavailable inhibitor of blood coagulation factor Xa

      JOURNAL OF MEDICINAL CHEMISTRY
    7. Chen, CP; Hsu, CH; Su, NY; Lin, YC; Chiou, SH; Wu, SH
      Solution structure of a Kunitz-type chymotrypsin inhibitor isolated from the elapid snake Bungarus fasciatus

      JOURNAL OF BIOLOGICAL CHEMISTRY
    8. Hayashi, M; Hamada, A; Okaya, Y; Wakitani, K; Aisaka, K
      Inhibitory effect of JTV-803, a new cyclic guanidine derivative, on factorXa in vitro and in vivo

      EUROPEAN JOURNAL OF PHARMACOLOGY
    9. Hayashi, M; Matsuo, A; Nakamoto, H; Aisaka, K
      Antithrombotic effects of a synthetic inhibitor of activated factor X, JTV-803, in animals

      EUROPEAN JOURNAL OF PHARMACOLOGY
    10. Lu, BY; Beck, PJ; Chang, JY
      Oxidative folding of murine prion mPrP(23-231)

      EUROPEAN JOURNAL OF BIOCHEMISTRY
    11. Chuang, YJ; Swanson, R; Raja, SM; Bock, SC; Olson, ST
      The antithrombin P1 residue is important for target proteinase specificitybut not for heparin activation of the serpin. Characterization of P1 antithrombin variants with altered proteinase specificity but normal heparin activation

      BIOCHEMISTRY
    12. Bednar, MM
      Stroke: antithrombin versus antiplatelet therapy

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    13. Leadley, RJ; Chi, LG; Rebello, SS; Gagnon, A
      Contribution of in vivo models of thrombosis to the discovery and development of novel antithrombotic agents

      JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
    14. St Charles, R; Padmanabhan, K; Arni, RV; Padmanabhan, KP; Tulinsky, A
      Structure of tick anticoagulant peptide at 1.6 angstrom, resolution complexed with bovine pancreatic trypsin inhibitor

      PROTEIN SCIENCE
    15. Chang, JY; Ballatore, A
      Structure and heterogeneity of the one- and two-disulfide folding intermediates of tick anticoagulant peptide

      JOURNAL OF PROTEIN CHEMISTRY
    16. Abendschein, DR; Baum, PK; Martin, DJ; Vergona, R; Post, J; Rumennik, G; Sullivan, ME; Eisenberg, PR; Light, DR
      Effects of ZK-807834, a novel inhibitor of factor Xa, on arterial and venous thrombosis in rabbits

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    17. Chu, V; Brown, K; Colussi, D; Choi, YM; Green, D; Pauls, HW; Spada, AP; Perrone, MH; Leadley, RJ; Dunwiddie, CT
      In vitro characterization of a novel factor Xa inhibitor, RPR 130737

      THROMBOSIS RESEARCH
    18. Dudley, DA; Bunker, AM; Chi, LG; Cody, WL; Holland, DR; Ignasiak, DP; Janiczek-Dolphin, N; McClanahan, TB; Mertz, TE; Narasimhan, LS; Rapundalo, ST; Trautschold, JA; Van Huis, CA; Edmunds, JJ
      Rational design, synthesis, and biological activity of benzoxazinones as novel factor Xa inhibitors

      JOURNAL OF MEDICINAL CHEMISTRY
    19. Grzesiak, A; Krokoszynska, I; Krowarsch, D; Buczek, O; Dadlez, M; Otlewski, J
      Inhibition of six serine proteinases of the human coagulation system by mutants of bovine pancreatic trypsin inhibitor

      JOURNAL OF BIOLOGICAL CHEMISTRY
    20. Chang, JY; Li, L; Canals, F; Aviles, FX
      The unfolding pathway and conformational stability of potato carboxypeptidase inhibitor

      JOURNAL OF BIOLOGICAL CHEMISTRY
    21. Chang, JY; Ballatore, A
      The structure of denatured bovine pancreatic trypsin inhibitor (BPTI)

      FEBS LETTERS
    22. Al-Obeidi, F; Ostrem, JA
      Factor Xa inhibitors

      EXPERT OPINION ON THERAPEUTIC PATENTS
    23. Arocha-Pinango, CL; Marchi, R; Carvajal, Z; Guerrero, B
      Invertebrate compounds acting on the hemostatic mechanism

      BLOOD COAGULATION & FIBRINOLYSIS
    24. Whitlow, M; Arnaiz, DO; Buckman, BO; Davey, DD; Griedel, B; Guilford, WJ; Koovakkat, SK; Liang, A; Mohan, R; Phillips, GB; Seto, M; Shaw, KJ; Xu, W; Zhao, ZC; Light, DR; Morrissey, MM
      Crystallographic analysis of potent and selective factor Xa inhibitors complexed to bovine trypsin

      ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
    25. Arocha-Pinango, CL; Marchi, R; Guerrero, B
      Inventory of exogenous hemostatic factors derived from arthropods - On behalf of the Registry of Exogenous Hemostatic Factors of the Scientific and Standardization Subcommittee of the International Society on Thrombosis and Haemostasis; Registry chairman: Neville Marsh

      THROMBOSIS AND HAEMOSTASIS
    26. Rogers, KL; Chi, L; Rapundalo, ST; Kramer, JB; Gallagher, KP
      Effects of a factor Xa inhibitor, DX-9065a, in a novel rabbit model of venous thrombosis

      BASIC RESEARCH IN CARDIOLOGY
    27. Rester, U; Bode, WR; Moser, M; Parry, MAA; Huber, R; Auerswald, E
      Structure of the complex of the antistasin-type inhibitor bdellastasin with trypsin and modelling of the bdellastasin-microplasmin system

      JOURNAL OF MOLECULAR BIOLOGY
    28. Klement, P; Liao, P; Bajzar, L
      A novel approach to arterial thrombolysis

      BLOOD
    29. Sabatine, MS; Jang, IK
      Antithrombotic therapy in acute coronary syndromes

      ACTA CARDIOLOGICA
    30. GULBA DC; BODE C; RUNGE MS; HUBER K
      THROMBOLYTIC AGENTS - AN UPDATED OVERVIEW

      FIBRINOLYSIS & PROTEOLYSIS
    31. ALOBEIDI F; OSTREM JA
      FACTOR XA INHIBITORS BY CLASSICAL AND COMBINATORIAL CHEMISTRY

      Drug discovery today
    32. KAWASAKI T; SATO K; HIRAYAMA F; KOSHIO H; TANIUCHI Y; MATSUMOTO Y
      EFFECT OF A SYNTHETIC FACTOR XA INHIBITOR, YM-60828, ON BLOOD-VESSEL PATENCY IN COMBINATION WITH A THROMBOLYTIC AGENT AND ON BLOOD-LOSS FROM THE OPERATION SITE IN A RAT MODEL OF ARTERIAL THROMBOSIS

      Thrombosis and haemostasis
    33. TANIUCHI Y; SAKAI Y; HISAMICHI N; KAYAMA M; MANO Y; SATO K; HIRAYAMA F; KOSHIO H; MATSUMOTO Y; KAWASAKI T
      BIOCHEMICAL AND PHARMACOLOGICAL CHARACTERIZATION OF YM-60828, A NEWLYSYNTHESIZED AND ORALLY-ACTIVE INHIBITOR OF HUMAN FACTOR XA

      Thrombosis and haemostasis
    34. LYLE EM; LEWIS SD; LEHMAN ED; GARDELL SJ; MOTZEL SL; LYNCH JJ
      ASSESSMENT OF THROMBIN INHIBITOR EFFICACY IN A NOVEL RABBIT MODEL OF SIMULTANEOUS ARTERIAL AND VENOUS THROMBOSIS

      Thrombosis and haemostasis
    35. SHAW KJ; GUILFORD WJ; DALLAS JL; KOOVAKKAAT SK; MCCARRICK MA; LIANG A; LIGHT DR; MORRISSEY MM
      ,Z)-2,7-BIS(4-AMIDINOBENZYLIDENE)CYCLEHEPTAN-1-ONE - IDENTIFICATION OF A HIGHLY-ACTIVE INHIBITOR OF BLOOD-COAGULATION FACTOR XA

      Journal of medicinal chemistry
    36. BAUGH RJ; BROZE GJ; KRISHNASWAMY S
      REGULATION OF EXTRINSIC PATHWAY FACTOR XA FORMATION BY TISSUE FACTOR PATHWAY INHIBITOR

      The Journal of biological chemistry
    37. MAO SS; PRZYSIECKI CT; KRUEGER JA; COOPER CM; LEWIS SD; JOYCE J; LELLIS C; GARSKY VM; SARDANA M; SHAFER JA
      SELECTIVE-INHIBITION OF FACTOR XA IN THE PROTHROMBINASE COMPLEX BY THE CARBOXYL-TERMINAL DOMAIN OF ANTISTASIN

      The Journal of biological chemistry
    38. BETZ A; KRISHNASWAMY S
      REGIONS REMOTE FROM THE SITE OF CLEAVAGE DETERMINE MACROMOLECULAR SUBSTRATE RECOGNITION BY THE PROTHROMBINASE COMPLEX

      The Journal of biological chemistry
    39. SATO K; KAWASAKI T; HISAMICHI N; TANIUCHI Y; HIRAYAMA F; KOSHIO H; MATSUMOTO Y
      ANTITHROMBOTIC EFFECTS OF YM-60828, A NEWLY SYNTHESIZED FACTOR XA INHIBITOR, IN RAT THROMBOSIS MODELS AND ITS EFFECTS ON BLEEDING-TIME

      British Journal of Pharmacology
    40. OSTREM JA; ALOBEIDI F; SAFAR P; SAFAROVA A; STRINGER SK; PATEK M; CROSS MT; SPOONAMORE J; LOCASCIO JC; KASIREDDY P; THORPE DS; SEPETOV N; LEBL M; WILDGOOSE P; STROP P
      DISCOVERY OF A NOVEL, POTENT, AND SPECIFIC FAMILY OF FACTOR XA INHIBITORS VIA COMBINATORIAL CHEMISTRY

      Biochemistry
    41. HANSON SR; SAKARIASSEN KS
      BLOOD-FLOW AND ANTITHROMBOTIC DRUG EFFECTS

      The American heart journal
    42. KAISER B
      FACTOR XA VERSUS FACTOR IIA INHIBITORS

      Clinical and applied thrombosis/hemostasis
    43. PRASA D; SVENDSEN L; STURZEBECHER JJ
      INHIBITION OF THROMBIN GENERATION IN PLASMA BY INHIBITORS OF FACTOR XA

      Thrombosis and haemostasis
    44. KOTZE HF; LAMPRECHT S; BADENHORST PN; ROODT JP; VANWYK V
      TRANSIENT INTERRUPTION OF ARTERIAL THROMBOSIS BY INHIBITION OF FACTORXA RESULTS IN LONG-TERM ANTITHROMBOTIC EFFECTS IN BABOONS

      Thrombosis and haemostasis
    45. YAMASHITA T; TSUJI T; MATSUOKA A; GIDDINGS JC; YAMAMOTO J
      THE ANTITHROMBOTIC EFFECT OF SYNTHETIC LOW-MOLECULAR-WEIGHT HUMAN FACTOR XA INHIBITOR DX-9065A, ON HE-NE LASER-INDUCED THROMBOSIS IN RAT MESENTERIC MICROVESSELS

      Thrombosis research
    46. KRISHNASWAMY S; WALKER RK
      CONTRIBUTION OF THE PROTHROMBIN FRAGMENT-2 DOMAIN TO THE FUNCTION OF FACTOR VA IN THE PROTHROMBINASE COMPLEX

      Biochemistry
    47. MCKENZIE CR; ABENDSCHEIN DR; EISENBERG PR
      SUSTAINED INHIBITION OF WHOLE-BLOOD CLOT PROCOAGULANT ACTIVITY BY INHIBITION OF THROMBUS-ASSOCIATED FACTOR XA

      Arteriosclerosis, thrombosis, and vascular biology
    48. MARKWARDT F
      ANTITHROMBOTIC AGENTS FROM HEMATOPHAGOUS ANIMALS

      Clinical and applied thrombosis/hemostasis
    49. NICOLINI FA; LEE P; MALYCKY JL; LEFKOVITS J; KOTTKEMARCHANT K; PLOW EF; TOPOL EJ
      SELECTIVE-INHIBITION OF FACTOR XA DURING THROMBOLYTIC THERAPY MARKEDLY IMPROVES CORONARY-ARTERY PATENCY IN A CANINE MODEL OF CORONARY-THROMBOSIS

      Blood coagulation & fibrinolysis
    50. PHILIPPIDES GJ; LOSCALZO J
      POTENTIAL ADVANTAGES OF DIRECT-ACTING THROMBIN INHIBITORS

      Coronary artery disease
    51. ABENDSCHEIN DR
      POTENTIAL ADVANTAGES OF NOVEL ANTITHROMBOTIC AGENTS ADMINISTERED CONJUNCTIVELY DURING CORONARY FIBRINOLYSIS

      Coronary artery disease
    52. KORNOWSKI R; ELDOR A; WERBER MM; EZOV N; ZWANG E; NIMROD A; CHERNINE A; FINKELSTEIN A; PANET A; LANIADO S; KEREN G
      ENHANCEMENT OF RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR THROMBOLYSIS WITH A SELECTIVE FACTOR XA INHIBITOR DERIVED FROM THE LEECH HIRUDO-MEDICINALIS - COMPARISON WITH HEPARIN AND HIRUDIN IN A RABBIT THROMBOSIS MODEL

      Coronary artery disease
    53. LEFKOVITS J; MALYCKY JL; RAO JS; HART CE; PLOW EF; TOPOL EJ; NICOLINI FA
      SELECTIVE-INHIBITION OF FACTOR XA IS MORE EFFICIENT THAN FACTOR VIIA-TISSUE FACTOR COMPLEX BLOCKADE AT FACILITATING CORONARY THROMBOLYSIS IN THE CANINE MODEL

      Journal of the American College of Cardiology
    54. WYSOKINSKI W; MCBANE R; CHESEBRO JH; OWEN WG
      REVERSIBILITY OF PLATELET THROMBOSIS IN-VIVO - QUANTITATIVE-ANALYSIS IN PORCINE CAROTID ARTERIES

      Thrombosis and haemostasis
    55. ELDOR A; OREVI M; RIGBI M
      THE ROLE OF THE LEECH IN MEDICAL THERAPEUTICS

      Blood reviews
    56. VANDELOCHT A; STUBBS MT; BODE W; FRIEDRICH T; BOLLSCHWEILER C; HOFFKEN W; HUBER R
      THE ORNITHODORIN-THROMBIN CRYSTAL-STRUCTURE, A KEY TO THE TAP ENIGMA

      EMBO journal
    57. RIGBI M; OREVI M; ELDOR A
      PLATELET-AGGREGATION AND COAGULATION INHIBITORS IN LEECH SALIVA AND THEIR ROLES IN LEECH THERAPY

      Seminars in thrombosis and hemostasis
    58. WONG PC; CRAIN EJ; NGUAN O; WATSON CA; RACANELLI A
      ANTITHROMBOTIC ACTIONS OF SELECTIVE INHIBITORS OF BLOOD-COAGULATION FACTOR XA IN RAT MODELS OF THROMBOSIS

      Thrombosis research
    59. GIKAKIS N; KHAN MMH; HIRAMATSU Y; GERMAN JH; HACK CE; SUN L; RAO AK; NIEWIAROWSKI S; COLMAN RW; EDMUNDS LH
      EFFECT OF FACTOR XA INHIBITORS ON THROMBIN FORMATION AND COMPLEMENT AND NEUTROPHIL ACTIVATION DURING IN-VITRO EXTRACORPOREAL-CIRCULATION

      Circulation
    60. SCHWARTZ RS; HOLDER DJ; HOLMES DR; VEINOT JP; CAMRUD AR; JORGENSON MA; JOHNSON RG
      NEOINTIMAL THICKENING AFTER SEVERE CORONARY-ARTERY INJURY IS LIMITED BY SHORT-TERM ADMINISTRATION OF A FACTOR XA INHIBITOR - RESULTS IN A PORCINE MODEL

      Circulation
    61. BIEMOND BJ; FRIEDERICH PW; LEVI M; VLASUK GP; BULLER HR; TENCATE JW
      COMPARISON OF SUSTAINED ANTITHROMBOTIC EFFECTS OF INHIBITORS OF THROMBIN AND FACTOR XA IN EXPERIMENTAL THROMBOSIS

      Circulation
    62. PIOTTE CP; GRIGOR MR
      A NOVEL MARSUPIAL PROTEIN EXPRESSED BY THE MAMMARY-GLAND ONLY DURING THE EARLY LACTATION AND RELATED TO THE KUNITZ PROTEINASE-INHIBITORS

      Archives of biochemistry and biophysics
    63. BONEU B
      ANTI-XA MOLECULES

      Archives des maladies du coeur et des vaisseaux
    64. ORVIM U; BARSTAD RM; VLASUK GP; SAKARIASSEN KS
      EFFECT OF SELECTIVE FACTOR XA INHIBITION ON ARTERIAL THROMBUS FORMATION TRIGGERED BY TISSUE FACTOR FACTOR VIIA OR COLLAGEN IN AN EX-VIVO MODEL OF SHEAR-DEPENDENT HUMAN THROMBOGENESIS/

      Arteriosclerosis, thrombosis, and vascular biology
    65. LYLE EM; FUJITA T; CONNER MW; CONNOLLY TM; VLASUK GP; LYNCH JL
      EFFECT OF INHIBITORS OF FACTOR X(A) OR PLATELET-ADHESION, HEPARIN, AND ASPIRIN ON PLATELET DEPOSITION IN AN ATHEROSCLEROTIC RABBIT MODEL OFANGIOPLASTY INJURY

      Journal of pharmacological and toxicological methods
    66. LYNCH JJ; SITKO GR; LEHMAN ED; VLASUK GP
      PRIMARY PREVENTION OF CORONARY ARTERIAL THROMBOSIS WITH THE FACTOR XAINHIBITOR RTAP IN A CANINE ELECTROLYTIC INJURY MODEL

      Thrombosis and haemostasis
    67. TURPIE AGG; WEITZ JI; HIRSH J
      ADVANCES IN ANTITHROMBOTIC THERAPY - NOVEL AGENTS

      Thrombosis and haemostasis
    68. RIPKA W; BRUNCK T; STANSSENS P; LAROCHE Y; LAUWEREYS M; LAMBEIR AM; LASTERS I; DEMAEYER M; VLASUK G; LEVY O; MILLER T; WEBB T; TAMURA S; PEARSON D
      STRATEGIES IN THE DESIGN OF INHIBITORS OF SERINE PROTEASES OF THE COAGULATION CASCADE - FACTOR XA

      European journal of medicinal chemistry
    69. VERSTRAETE M
      NEW DEVELOPMENTS IN ANTIPLATELET AND ANTITHROMBOTIC THERAPY

      European heart journal
    70. RIHAL CS; FLATHER M; HIRSH J; YUSUF S
      ADVANCES IN ANTITHROMBOTIC DRUG-THERAPY FOR CORONARY-ARTERY DISEASE

      European heart journal
    71. SANYAL G; MARQUISOMER D; WAXMAN L; MACH H; RYAN JA; GRESS JO; MIDDAUGH CR
      SPECTROSCOPIC CHARACTERIZATION OF TICK ANTICOAGULANT PEPTIDE

      Biochimica et biophysica acta. Protein structure and molecular enzymology
    72. VERSTRAETE M; ZOLDHELYI P
      NOVEL ANTITHROMBOTIC DRUGS IN DEVELOPMENT

      Drugs
    73. PRAGER NA; ABENDSCHEIN DR; MCKENZIE CR; EISENBERG PR
      ROLE OF THROMBIN COMPARED WITH FACTOR XA IN THE PROCOAGULANT ACTIVITYOF WHOLE-BLOOD CLOTS

      Circulation
    74. YOKOYAMA T; KELLY AB; MARZEC UM; HANSON SR; KUNITADA S; HARKER LA
      ANTITHROMBOTIC EFFECTS OF ORALLY-ACTIVE SYNTHETIC ANTAGONIST OF ACTIVATED FACTOR-X IN NONHUMAN-PRIMATES

      Circulation
    75. JANG YS; GUZMAN LA; LINCOFF AM; GOTTSAUNERWOLF M; FORUDI F; HART CE; COURTMAN DW; EZBAN M; ELLIS SG; TOPOL EJ
      INFLUENCE OF BLOCKADE AT SPECIFIC LEVELS OF THE COAGULATION CASCADE ON RESTENOSIS IN A RABBIT ATHEROSCLEROTIC FEMORAL-ARTERY INJURY MODEL

      Circulation
    76. CLAESON G
      SYNTHETIC PEPTIDES AND PEPTIDOMIMETICS AS SUBSTRATES AND INHIBITORS OF THROMBIN AND OTHER PROTEASES IN THE BLOOD-COAGULATION SYSTEM

      Blood coagulation & fibrinolysis
    77. HARKER LA
      STRATEGIES FOR INHIBITING THE EFFECTS OF THROMBIN

      Blood coagulation & fibrinolysis
    78. MARKWARDT F
      INVENTORY OF COAGULATION INHIBITORS FROM ANIMALS FEEDING ON BLOOD

      Thrombosis and haemostasis
    79. EISENBERG PR
      THROMBOSIS AND FIBRINOLYSIS IN ACUTE MYOCARDIAL-INFARCTION

      Alcoholism, clinical and experimental research
    80. MARKWARDT F
      COAGULATION INHIBITORS FROM BLOODSUCKING ANIMALS - A NEW LINE OF DEVELOPING ANTITHROMBOTIC DRUGS

      Die Pharmazie
    81. LEFKOVITS J; TOPOL EJ
      DIRECT THROMBIN INHIBITORS IN CARDIOVASCULAR MEDICINE

      Circulation
    82. RAGOSTA M; GIMPLE LW; GERTZ SD; DUNWIDDIE CT; VLASUK GP; HABER HL; POWERS ER; ROBERTS WC; SAREMBOCK IJ
      SPECIFIC FACTOR XA INHIBITION REDUCES RESTENOSIS AFTER BALLOON ANGIOPLASTY OF ATHEROSCLEROTIC FEMORAL ARTERIES IN RABBITS

      Circulation
    83. LYNCH JJ; SITKO GR; MELLOTT MJ; NUTT EM; LEHMAN ED; FRIEDMAN PA; DUNWIDDIE CT; VLASUK GP
      MAINTENANCE OF CANINE CORONARY-ARTERY PATENCY FOLLOWING THROMBOLYSIS WITH FRONT LOADED PLUS LOW-DOSE MAINTENANCE CONJUNCTIVE THERAPY - A COMPARISON OF FACTOR XA VERSUS THROMBIN INHIBITION

      Cardiovascular Research
    84. LIU LB; FREEDMAN J; HORNSTEIN A; FENTON JW; OFOSU FA
      THROMBIN BINDING TO PLATELETS AND THEIR ACTIVATION IN PLASMA

      British Journal of Haematology
    85. GRUBER A; MORI E; DELZOPPO GJ; WAXMAN L; GRIFFIN JH
      ALTERATION OF FIBRIN NETWORK BY ACTIVATED PROTEIN-C

      Blood
    86. MACH H; MIDDAUGH CR
      SIMULTANEOUS MONITORING OF THE ENVIRONMENT OF TRYPTOPHAN, TYROSINE, AND PHENYLALANINE RESIDUES IN PROTEINS BY NEAR-ULTRAVIOLET 2ND-DERIVATIVE SPECTROSCOPY

      Analytical biochemistry
    87. LEHMAN ED; JOYCE JG; BAILEY FJ; MARKUS HZ; SCHULTZ LD; DUNWIDDIE CT; JACOBSON MA; MILLER WJ
      EXPRESSION, PURIFICATION AND CHARACTERIZATION OF MULTIGRAM AMOUNTS OFA RECOMBINANT HYBRID HV1-HV2 HIRUDIN VARIANT EXPRESSED IN SACCHAROMYCES-CEREVISIAE

      Protein expression and purification
    88. CADROY Y; HANSON SR; HARKER LA
      ANTITHROMBOTIC EFFECTS OF SYNTHETIC PENTASACCHARIDE WITH HIGH-AFFINITY FOR PLASMA ANTITHROMBIN-III IN NONHUMAN-PRIMATES

      Thrombosis and haemostasis
    89. FIORAVANTI C; BURKHOLDER D; FRANCIS B; SIEGL PKS; GIBSON RE
      ANTITHROMBOTIC ACTIVITY OF RECOMBINANT TICK ANTICOAGULANT PEPTIDE ANDHEPARIN IN A RABBIT MODEL OF VENOUS THROMBOSIS

      Thrombosis research
    90. EISENBERG PR; SIEGEL JE; ABENDSCHEIN DR; MILETICH JP
      IMPORTANCE OF FACTOR-XA IN DETERMINING THE PROCOAGULANT ACTIVITY OF WHOLE-BLOOD CLOTS

      The Journal of clinical investigation
    91. ZOLDHELYI P; WEBSTER MWI; FUSTER V; GRILL DE; GASPAR D; EDWARDS SJ; CABOT CF; CHESEBRO JH
      RECOMBINANT HIRUDIN IN PATIENTS WITH CHRONIC, STABLE CORONARY-ARTERY DISEASE - SAFETY, HALF-LIFE, AND EFFECT ON COAGULATION PARAMETERS

      Circulation
    92. AGNELLI G
      NEW STRATEGIES FOR ENHANCING THE SPEED AND RATE OF CORONARY REPERFUSION

      The American journal of cardiology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 21/10/20 alle ore 19:16:54